Found: 65
Select item for more details and to access through your institution.
Samarium-153-(4-[((bis (phosphonomethyl)) carbamoyl) methyl]-7,10-bis (carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl) acetic acid: A novel agent for bone pain palliation therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Production, quality control, and determination of human absorbed dose of no carrier added <sup>177</sup>Lu-risedronate for bone pain palliation therapy.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2017, v. 60, n. 1, p. 20, doi. 10.1002/jlcr.3466
- By:
- Publication type:
- Article
Preclinical evaluation of holmium-166 labeled anti-VEGF-A(Bevacizumab).
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2013, v. 56, n. 8, p. 365, doi. 10.1002/jlcr.3044
- By:
- Publication type:
- Article
Development of <sup>170</sup>Tm-DOTA-cetuximab for radioimmunotherapy.
- Published in:
- Journal of Labelled Compounds & Radiopharmaceuticals, 2012, v. 55, n. 3, p. 103, doi. 10.1002/jlcr.1957
- By:
- Publication type:
- Article
Metastatic Bone Pain Palliation using <sup>177</sup>Lu-Ethylenediaminetetramethylene Phosphonic Acid.
- Published in:
- World Journal of Nuclear Medicine, 2015, v. 14, n. 2, p. 109, doi. 10.4103/1450-1147.157124
- By:
- Publication type:
- Article
Development of <sup>166</sup>Holmium-1,2 Propylene Di-amino Tetra (Methy1enephosphonicacid) as a Possible Bone Palliation Agent.
- Published in:
- World Journal of Nuclear Medicine, 2014, v. 13, n. 1, p. 28, doi. 10.4103/1450-1147.138571
- By:
- Publication type:
- Article
Production, Quality Control and Biological Evaluation of <sup>166</sup>Ho-PDTMP as a Possible Bone Palliation Agent.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2013, v. 16, n. 5, p. 720
- By:
- Publication type:
- Article
Development of <sup>177</sup>Lu-phytate Complex for Radiosynovectomy.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2013, v. 16, n. 5, p. 704
- By:
- Publication type:
- Article
Preparation and Quality Control of <sup>68</sup>Ga-Citrate for PET Applications.
- Published in:
- Asia Oceania Journal of Nuclear Medicine & Biology, 2015, v. 3, n. 2, p. 99
- By:
- Publication type:
- Article
ESTIMATION OF HUMAN DOSE OF <sup>188/186</sup>RE-HEDP COCKTAIL BASED ON OLINDA/EXM AND DISTRIBUTION DATA IN RATS.
- Published in:
- Radiation Protection Dosimetry, 2020, v. 190, n. 2, p. 158, doi. 10.1093/rpd/ncaa087
- By:
- Publication type:
- Article
Enriched 146Nd recovery from a 147Pm production process by applying ion imprinting technique.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2021, v. 327, n. 2, p. 761, doi. 10.1007/s10967-020-07560-4
- By:
- Publication type:
- Article
Radiolabeled TPP with <sup>166</sup>Dy/<sup>166</sup>Ho in vivo generator as a novel therapeutic agent.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2020, v. 326, n. 1, p. 813, doi. 10.1007/s10967-020-07364-6
- By:
- Publication type:
- Article
Evaluation of promethium-147 production by irradiating natural neodymium using medium-flux Tehran research reactor.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2020, v. 326, n. 1, p. 465, doi. 10.1007/s10967-020-07301-7
- By:
- Publication type:
- Article
Appraisement of <sup>186/188</sup>Re-HEDP, a new compositional radiopharmaceutical.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2019, v. 322, n. 2, p. 1133, doi. 10.1007/s10967-019-06816-y
- By:
- Publication type:
- Article
The role of organic acids on Ra transfer factor in corn ( Zea mays L.).
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2017, v. 313, n. 1, p. 13, doi. 10.1007/s10967-017-5265-3
- By:
- Publication type:
- Article
Preparation of Dy/Ho-chitosan as an in vivo generator for radiosynovectomy.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2017, v. 311, n. 3, p. 1657, doi. 10.1007/s10967-016-5146-1
- By:
- Publication type:
- Article
Determination of human absorbed dose of cocktail of Sm/Lu-EDTMP, based on biodistribution data in rats.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2016, v. 307, n. 2, p. 1439, doi. 10.1007/s10967-015-4324-x
- By:
- Publication type:
- Article
Preparation and biological evaluation of Ho-BPAMD as a potential therapeutic bone-seeking agent.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2015, v. 304, n. 3, p. 1285, doi. 10.1007/s10967-014-3924-1
- By:
- Publication type:
- Article
Production of Ra from Ra in Tehran Research Reactor for treatment of bone metastases.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2015, v. 304, n. 3, p. 1185, doi. 10.1007/s10967-015-3931-x
- By:
- Publication type:
- Article
Development of In DOTMP for dosimetry of bone pain palliation agents.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2015, v. 304, n. 2, p. 911, doi. 10.1007/s10967-014-3911-6
- By:
- Publication type:
- Article
Evaluation of Sm/Lu-EDTMP mixture in wild-type rodents as a novel combined palliative treatment of bone pain agent.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2015, v. 303, n. 1, p. 71, doi. 10.1007/s10967-014-3342-4
- By:
- Publication type:
- Article
Radiosynthesis and biological evaluation of Ho labeled methoxylated porphyrins as possible therapeutic agents.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2014, v. 301, n. 1, p. 269, doi. 10.1007/s10967-014-3113-2
- By:
- Publication type:
- Article
Production, quality control and pharmacokinetic studies of Lu-zoledronate for bone pain palliation therapy.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2013, v. 298, n. 2, p. 1273, doi. 10.1007/s10967-013-2490-2
- By:
- Publication type:
- Article
Preparation and quality control and biodistribution studies of [Y]-DOTA-cetuximab for radioimmunotherapy.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2013, v. 296, n. 3, p. 1287, doi. 10.1007/s10967-013-2426-x
- By:
- Publication type:
- Article
Development and evaluation of a holmium labelled porphyrin complex as a possible therapeutic agent.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2013, v. 295, n. 2, p. 979, doi. 10.1007/s10967-012-2034-1
- By:
- Publication type:
- Article
Production and quality control of [Ho]-DOTA-bevacizumab for therapeutic applications.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2012, v. 292, n. 3, p. 1065, doi. 10.1007/s10967-012-1640-2
- By:
- Publication type:
- Article
Development of Lu-DOTA-anti-CD20 for radioimmunotherapy.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2011, v. 287, n. 1, p. 199, doi. 10.1007/s10967-010-0676-4
- By:
- Publication type:
- Article
Development of Ho bleomycin as a possible therapeutic complex.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2010, v. 285, n. 3, p. 461, doi. 10.1007/s10967-010-0589-2
- By:
- Publication type:
- Article
Evaluation of promethium-147 production as a by-product of the fission molybdenum-99 process in Tehran research reactor.
- Published in:
- Radiochimica Acta, 2021, v. 109, n. 4, p. 295, doi. 10.1515/ract-2020-0081
- By:
- Publication type:
- Article
Production, Quality Control and Pharmacokinetic Studies of <sup>177</sup>Lu-EDTMP for Human Bone Pain Palliation Therapy Trials.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2012, v. 11, n. 1, p. 137
- By:
- Publication type:
- Article
Toxicity of nano and bulk forms of Cerium oxide in different cell lines.
- Published in:
- Iranian Journal of Pharmacology & Therapeutics, 2018, v. 16, n. 1, p. 1
- By:
- Publication type:
- Article
Feasibility study for production and quality control of Yb-175 as a byproduct of no carrier added Lu-177 preparation for radiolabeling of DOTMP.
- Published in:
- Australasian Physical & Engineering Sciences in Medicine, 2018, v. 41, n. 1, p. 69, doi. 10.1007/s13246-017-0611-x
- By:
- Publication type:
- Article
A comprehensive investigation of an approach for <sup>144</sup>Ce-separation as a by-product of the fission molybdenum-99 process.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2024, v. 333, n. 2, p. 815, doi. 10.1007/s10967-023-09302-8
- By:
- Publication type:
- Article
Preclinical evaluation of<sup>188</sup>Re-HYNIC-PSMA as a novel therapeutic agent.
- Published in:
- Journal of Radioanalytical & Nuclear Chemistry, 2022, v. 331, n. 2, p. 841, doi. 10.1007/s10967-021-08173-1
- By:
- Publication type:
- Article
Development of <sup>166</sup>Ho-zoledronate as a bone marrow ablative agent.
- Published in:
- Pharmaceutical & Biomedical Research, 2016, v. 2, n. 1, p. 14, doi. 10.18869/acadpub.pbr.2.1.14
- By:
- Publication type:
- Article
Optimization of Natural Rhenium Irradiation Time to Produce Compositional Radiopharmaceutical.
- Published in:
- Iranian Journal of Medical Physics / Majallah-I Fīzīk-I Pizishkī-i Īrān, 2019, v. 16, n. 5, p. 362, doi. 10.22038/ijmp.2018.33853.1421
- By:
- Publication type:
- Article
Investigation of on-site implications of tea plantations on soil erosion in Iran using <sup>137</sup>Cs method and RUSLE.
- Published in:
- Environmental Earth Sciences, 2021, v. 80, n. 1, p. 1, doi. 10.1007/s12665-020-09347-y
- By:
- Publication type:
- Article
Preparation and biological evaluation of <sup>186/188</sup>Re-HEDP as a new cocktail radiopharmaceutical for palliative treatment of osseous metastases in wild type rat.
- Published in:
- Iranian Journal of Nuclear Medicine, 2021, v. 29, n. 1, p. 8
- By:
- Publication type:
- Article
Production of no-carrier-added Ho-166 for targeted therapy purposes.
- Published in:
- Iranian Journal of Nuclear Medicine, 2017, v. 25, p. 15
- By:
- Publication type:
- Article
Comparative studies of extraction chromatography and electroamalgamation separation to produce no-carrier added <sup>177</sup>Lu by Tehran research reactor.
- Published in:
- Iranian Journal of Nuclear Medicine, 2017, v. 25, n. 1, p. 23
- By:
- Publication type:
- Article
Development of <sup>153</sup>Sm/<sup>177</sup>Lu-EDTMP as a possible therapeutic complex.
- Published in:
- Iranian Journal of Nuclear Medicine, 2017, v. 25, n. 1, p. 11
- By:
- Publication type:
- Article
Preclinical studies of <sup>166</sup>Ho-chitosan for treatment of hepatocellular carcinoma.
- Published in:
- Iranian Journal of Nuclear Medicine, 2016, v. 24, n. 1, p. 59
- By:
- Publication type:
- Article
Radiolabeling and evaluation of two <sup>177</sup>Lu-labeled bis-phosphonates.
- Published in:
- Iranian Journal of Nuclear Medicine, 2015, v. 23, n. 2, p. 108
- By:
- Publication type:
- Article
Preparation of a <sup>153</sup>Sm-5,10,15,20-tetrakis(4-methoxyphenyl) porphyrin complex as a possible therapeutic agent.
- Published in:
- Iranian Journal of Nuclear Medicine, 2015, v. 23, n. 2, p. 65
- By:
- Publication type:
- Article
Preparation and preliminary biological evaluation of [<sup>153</sup> Sm] samarium AMD3100; towards a possible therapeutic chemokine receptor CXCR4 targeting complex.
- Published in:
- Iranian Journal of Nuclear Medicine, 2015, v. 23, n. 1, p. 36
- By:
- Publication type:
- Article
Radiosynthesis and evaluation of ytterbium-175 labeled bleomycin as therepeutic agent.
- Published in:
- Iranian Journal of Nuclear Medicine, 2014, v. 22, n. 2, p. 40
- By:
- Publication type:
- Article
Preparation and quality control of <sup>177</sup>Lu-chitosan for radiosynovectomy.
- Published in:
- Iranian Journal of Nuclear Medicine, 2014, v. 22, n. 1, p. 1
- By:
- Publication type:
- Article
Production, quality control and biological evaluation of <sup>153</sup>Sm-TTHMP as a possible bone palliation agent.
- Published in:
- Iranian Journal of Nuclear Medicine, 2011, v. 19, n. 2, p. 60
- By:
- Publication type:
- Article
Development of Sm-153 Chitosan for Radiosynovectomy.
- Published in:
- Iranian Journal of Nuclear Medicine, 2010, v. 18, n. 1, p. 22
- By:
- Publication type:
- Article
Production, Quality Control and Biological Evaluation of <sup>153</sup>Sm-EDTMP in Wild-Type Rodents.
- Published in:
- Iranian Journal of Nuclear Medicine, 2009, v. 17, n. 2, p. 12
- By:
- Publication type:
- Article